Cerity Partners
MIRM icon

Cerity Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Cerity Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Sell
2,435
-18
-0.7% -$1.81K ﹤0.01% 2836
2026
Q1 		$227K Buy
+2,453
New +$231K ﹤0.01% 2804

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerity Partners's MIRM Position: Q2 2026 in Review

Cerity Partners reduced its Mirum Pharmaceuticals (MIRM) stake by 0.73% in Q2 2026, selling an estimated $1.81K and leaving 2,435 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2836.

Cerity Partners first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Cerity Partners held 2,435 shares of Mirum Pharmaceuticals worth $285K as of Q2 2026.
  • Cerity Partners sold 18 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.81K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2836 holding.
  • Cerity Partners first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.